Edition:
India

Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

100.13USD
20 Feb 2018
Change (% chg)

$-1.47 (-1.45%)
Prev Close
$101.60
Open
$100.85
Day's High
$100.85
Day's Low
$98.80
Volume
10,898
Avg. Vol
36,987
52-wk High
$128.25
52-wk Low
$93.59

Chart for

About

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical... (more)

Overall

Beta: 0.66
Market Cap(Mil.): $4,626.61
Shares Outstanding(Mil.): 40.51
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Taro Pharmaceutical Industries Posts Q3 Earnings Per Share $0.45

* ‍EXCLUDING IMPACT OF ONE-TIME TAX RE-MEASUREMENT, EARNINGS PER SHARE FOR QUARTER WOULD BE $1.37​ Source text for Eikon: Further company coverage:

08 Feb 2018

BRIEF-Bellus Health Receives Milestone Payment From Taro Pharmaceuticals

* BELLUS HEALTH RECEIVES MILESTONE PAYMENT FROM TARO PHARMACEUTICALS Source text for Eikon: Further company coverage:

09 Jan 2018

BRIEF-Taro Pharmaceutical quarterly earnings per share $1.30

* Taro Pharmaceutical Industries Ltd-qtrly ‍shr $1.30​ Source text for Eikon: Further company coverage:

08 Nov 2017

BRIEF-Taro announces joining of CEO

* Taro Pharmaceutical Industries Ltd - ‍ Uday Baldota has joined company as its chief executive officer ("CEO") effective August 28, 2017​

02 Sep 2017

Earnings vs. Estimates